Skip to main content
. 2022 Oct;10(20):1093. doi: 10.21037/atm-21-6415

Table 3. A total of 14 major components that acted on hemostasis-related hub targets.

No. Compound Formula MW OB (%) DL Count Target
F5 Genistein C15H10O5 270.24 17.93 0.21 15 AKT1, CDKN1A, EGFR, ESR1, HIF1A, IL6, MAPK1, MAPK14, RELA, STAT1, STAT3, TGFB1, TNF, TP53, VEGFA
F6 Quercetin C15H10O7 302.25 46.43 0.28 15 AKT1, CDKN1A, EGFR, HIF1A, IL6, JUN, MAPK1, PIK3R1, RELA, SRC, STAT1, TGFB1, TNF, TP53, VEGFA
T2 Ursolic acid C30H48O3 456.78 16.77 0.75 8 CDKN1A, CREB1, IL6, RELA, STAT3, TNF, TP53, VEGFA
F7 Kaempferol C15H10O6 286.25 41.88 0.24 4 AKT1, RELA, STAT1, TNF
P12 Paeonol C9H10O3 166.19 28.79 0.04 4 AKT1, MAPK1, RELA, TNF
F1 Rutin C27H30O16 610.57 3.2 0.68 3 IL6, RELA, TNF
P42 Lauric acid C12H24O2 200.36 23.59 0.04 3 AKT1, IL6, RELA
F10 Chrysin C15H10O4 254.25 22.61 0.18 2 CDKN1A, TGFB1
F11 Corymbosin C19H18O7 358.37 51.96 0.41 2 ESR1, MAPK14
T9 Beta-sitosterol C29H50O 414.79 36.91 0.75 1 TGFB1
F8 3-Methylkempferol C16H12O6 300.28 60.16 0.26 1 MAPK14
P1 Caffeic acid C9H8O4 180.17 25.76 0.05 1 TNF
O6 Hexanal C6H12O 100.18 55.71 0.01 1 TNF
O12 Farnesol C15H26O 222.41 28.44 0.06 1 IL6

MW, molecular weight; OB, oral bioavailability; DL, drug-likeness.